Drugs / [99mTc]Tc-G3-(G3S)3C
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05923268 | Jun 2023 → Jun 2024 | female breast carcinoma | Tomsk National Research Medical Center of the Russian Academy of Sciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [99mTc]Tc-G3-(G3S)3C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05923268 ↗ |
| Modality | Protein / enzyme biologic | “Technetium-99m-labelled Designed Ankyrin Repeat Proteins ([99mTc]Tc-G3-(G3S)3C)” NCT05923268 ↗ |